AU2017275081B2 - Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same - Google Patents

Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same Download PDF

Info

Publication number
AU2017275081B2
AU2017275081B2 AU2017275081A AU2017275081A AU2017275081B2 AU 2017275081 B2 AU2017275081 B2 AU 2017275081B2 AU 2017275081 A AU2017275081 A AU 2017275081A AU 2017275081 A AU2017275081 A AU 2017275081A AU 2017275081 B2 AU2017275081 B2 AU 2017275081B2
Authority
AU
Australia
Prior art keywords
hemoglobin
number nite
monoclonal antibody
npmd
insoluble carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2017275081A
Other languages
English (en)
Other versions
AU2017275081A1 (en
AU2017275081A2 (en
Inventor
Mitsuru Makinodan
Chisa Sakanishi
Yasuhiro Seki
Ryota YASUI
Megumi Yui
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eiken Chemical Co Ltd
Original Assignee
Eiken Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eiken Chemical Co Ltd filed Critical Eiken Chemical Co Ltd
Publication of AU2017275081A1 publication Critical patent/AU2017275081A1/en
Publication of AU2017275081A2 publication Critical patent/AU2017275081A2/en
Application granted granted Critical
Publication of AU2017275081B2 publication Critical patent/AU2017275081B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies; monoclonal antibodies per se are classified with their corresponding antigens
    • G01N33/57535—
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/544—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being organic
    • G01N33/545—Synthetic resin
    • G01N33/546—Synthetic resin as water suspendable particles
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57419—Specifically defined cancers of colon
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721—Haemoglobin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2017275081A 2016-05-30 2017-05-26 Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same Active AU2017275081B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016107343 2016-05-30
JP2016-107343 2016-05-30
PCT/JP2017/019736 WO2017209001A1 (ja) 2016-05-30 2017-05-26 抗ヒトヘモグロビンモノクローナル抗体若しくは抗体キット、抗ヒトヘモグロビンモノクローナル抗体固定化不溶性担体粒子、及びこれらを用いた測定試薬若しくは測定方法

Publications (3)

Publication Number Publication Date
AU2017275081A1 AU2017275081A1 (en) 2019-01-03
AU2017275081A2 AU2017275081A2 (en) 2019-01-17
AU2017275081B2 true AU2017275081B2 (en) 2023-12-07

Family

ID=60477766

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2017275081A Active AU2017275081B2 (en) 2016-05-30 2017-05-26 Anti-human hemoglobin monoclonal antibody or antibody kit, insoluble carrier particle to which anti-human hemoglobin monoclonal antibody is immobilized, and measurement reagent and measurement method using same

Country Status (10)

Country Link
US (1) US11175292B2 (enExample)
EP (1) EP3467498B1 (enExample)
JP (2) JP6991968B2 (enExample)
KR (1) KR102433648B1 (enExample)
CN (1) CN110383067B (enExample)
AU (1) AU2017275081B2 (enExample)
ES (1) ES2985318T3 (enExample)
SG (1) SG11201809558PA (enExample)
TW (1) TWI800483B (enExample)
WO (1) WO2017209001A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112752974A (zh) * 2018-09-26 2021-05-04 荣研化学株式会社 血红蛋白的测定试剂、测定试剂盒和测定方法
CN112979799B (zh) * 2019-12-18 2022-11-08 东莞市朋志生物科技有限公司 一种包含血红蛋白抗原结构域的结合蛋白
CN111057150B (zh) * 2019-12-30 2021-10-29 深圳开立生物医疗科技股份有限公司 一种乳胶微球及其应用以及糖化血红蛋白检测试剂盒
CN114478759A (zh) * 2020-11-12 2022-05-13 东莞市朋志生物科技有限公司 抗人血红蛋白的抗体及其应用和诊断试剂盒

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05322888A (ja) * 1992-05-18 1993-12-07 Toyobo Co Ltd 遊離ヘモグロビンの定量方法および遊離ヘモグロビン定量キット
US20080227208A1 (en) * 2007-03-16 2008-09-18 Hsiao-Ching Yee Devices and Methods for Detection of Occult Blood
US20150219658A1 (en) * 2012-07-09 2015-08-06 Schebo Biotech Ag Test kit (combi quick test) for the synchronous proof of biomarkers in faeces for detecting of pathological changes in the gastrointestinal tract, particularly in the intestine

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61137064A (ja) 1984-12-07 1986-06-24 Fujirebio Inc 大腸癌の予備スクリ−ニング方法
JPH02193071A (ja) 1989-01-20 1990-07-30 Green Cross Corp:The ハプトグロビン―ヘモグロビン複合体測定用試薬キット及びそれを用いるハプトグロビン―ヘモグロビン複合体の測定法
US5552295A (en) 1994-03-02 1996-09-03 The United States Of America As Represented By The Secretary Of Agriculture Monoclonal antibodies to bovine haptoglobin and methods for detecting serum haptoglobin levels
US6342219B1 (en) * 1999-04-28 2002-01-29 Board Of Regents, The University Of Texas System Antibody compositions for selectively inhibiting VEGF
TWI235159B (en) 1999-06-30 2005-07-01 Dev Center Biotechnology Anti-human hemoglobin monoclonal antibodies for detecting fecal occult blood, producing hybridomas and uses thereof
JP2001221800A (ja) 2000-02-14 2001-08-17 Internatl Reagents Corp 複合体の測定方法
JP4390963B2 (ja) 2000-04-05 2009-12-24 シスメックス株式会社 免疫測定方法及び試薬キット
US7166476B2 (en) * 2000-08-29 2007-01-23 Kyowa Medex Co., Ltd. Highly reproducible agglutination immunoassay method and reagents
JP5227418B2 (ja) * 2007-11-20 2013-07-03 エフ．ホフマン−ラ ロシュ アーゲー マーカー組み合わせカルプロテクチンおよびヘモグロビン／ハプトグロビン複合体の使用による便試料からの結腸直腸癌の評価方法
CN101236210A (zh) * 2008-01-29 2008-08-06 王学生 快速联检血红蛋白-结合珠蛋白复合物和大便潜血试剂
JP5191291B2 (ja) 2008-07-04 2013-05-08 和光純薬工業株式会社 便検体中ヘモグロビンの測定方法及び測定試薬キット
WO2010013525A1 (ja) 2008-07-31 2010-02-04 日東紡績株式会社 複合体の測定方法およびそれに用いるキット
CN104515859A (zh) * 2014-12-17 2015-04-15 杭州慧缘泰医疗器械有限公司 血红蛋白、血红蛋白-结合珠蛋白复合物、转铁蛋白联检试剂盒及其制备方法、检测方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05322888A (ja) * 1992-05-18 1993-12-07 Toyobo Co Ltd 遊離ヘモグロビンの定量方法および遊離ヘモグロビン定量キット
US20080227208A1 (en) * 2007-03-16 2008-09-18 Hsiao-Ching Yee Devices and Methods for Detection of Occult Blood
US20150219658A1 (en) * 2012-07-09 2015-08-06 Schebo Biotech Ag Test kit (combi quick test) for the synchronous proof of biomarkers in faeces for detecting of pathological changes in the gastrointestinal tract, particularly in the intestine

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
IVO R. HORN ET AL: "Generation of a haptoglobin-hemoglobin complex-specific Fab antibody blocking the binding of the complex to CD163", EUROPEAN JOURNAL OF HAEMATOLOGY., vol. 71, no. 4, 1 October 2003 (2003-10-01), DK, pages 289 - 293 *

Also Published As

Publication number Publication date
KR20190015338A (ko) 2019-02-13
AU2017275081A1 (en) 2019-01-03
JP6991968B2 (ja) 2022-01-13
EP3467498B1 (en) 2024-07-03
US11175292B2 (en) 2021-11-16
JPWO2017209001A1 (ja) 2019-03-28
CN110383067B (zh) 2023-07-21
AU2017275081A2 (en) 2019-01-17
KR102433648B1 (ko) 2022-08-17
CN110383067A (zh) 2019-10-25
EP3467498A4 (en) 2019-11-13
TW201802472A (zh) 2018-01-16
EP3467498A1 (en) 2019-04-10
TWI800483B (zh) 2023-05-01
ES2985318T3 (es) 2024-11-05
JP2022033935A (ja) 2022-03-02
US20200319183A1 (en) 2020-10-08
WO2017209001A1 (ja) 2017-12-07
SG11201809558PA (en) 2018-12-28
JP7386220B2 (ja) 2023-11-24

Similar Documents

Publication Publication Date Title
EP2322562B1 (en) Monoclonal antibody, and immunoassay using same
JP7386220B2 (ja) 抗ヒトヘモグロビンモノクローナル抗体若しくは抗体キット、抗ヒトヘモグロビンモノクローナル抗体固定化不溶性担体粒子、及びこれらを用いた測定試薬若しくは測定方法
KR102520342B1 (ko) 트롬빈 안티트롬빈 복합체의 측정 시약 및 측정 방법
JP6016789B2 (ja) Ｐｉｖｋａ−ｉｉ測定試薬における非特異反応の抑制方法
JP2014206391A (ja) ラテックス免疫凝集測定試薬
EP4286850A1 (en) Immunological assay method
HK40011144A (en) Anti-human hemoglobin monoclonal antibody or antibody kit, antibody-immobilized insoluble carrier particle and use of them
JP5028020B2 (ja) Ｎ１，ｎ８−ジアセチルスペルミジンに対する高特異性モノクローナル抗体
HK40011144B (zh) 抗人血红蛋白单克隆抗体或抗体试剂盒、抗体固定化不溶性载体粒子和它们的应用
Fremy et al. Policy on characterisation of antibodies used in immunochemical methods of analysis for mycotoxins and phycotoxins
HK1195123A (en) Method for inhibiting non-specific reaction in pivka-ii measurement reagent
HK1195123B (en) Method for inhibiting non-specific reaction in pivka-ii measurement reagent
JP2014206393A (ja) Ｍｍｐ−３の測定方法

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS AS SHOWN IN THE STATEMENT(S) FILED 04 DEC 2018 AND 20 DEC 2018

NA Applications received for extensions of time, section 223

Free format text: AN APPLICATION TO EXTEND THE TIME FROM 06 DEC 2017 TO 06 JAN 2019 IN WHICH TO COMPLY WITH SECTION 6(C) HAS BEEN FILED

NB Applications allowed - extensions of time section 223(2)

Free format text: THE TIME IN WHICH TO COMPLY WITH SECTION 6(C) HAS BEEN EXTENDED TO 06 JAN 2019

FGA Letters patent sealed or granted (standard patent)